DIFFUSE LARGE B-CELL LYMPHOMA - World …
DIFFUSE LARGE B-CELL LYMPHOMA Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines !! ! ! 1!
Download DIFFUSE LARGE B-CELL LYMPHOMA - World …
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
MULTIPLE MYELOMA (MM) - Celgene
media.celgene.comArea of Research Phase 1 Phase 2 Phase 3 Post-Approval Research C C F P- esear C- C- T T appr LYMPHOMA REVLIMID® (lenalidomide) Mantle cell lymphoma: Relapsed/refractory . . . . . . . . . . Diffuse large B-cell lymphoma (ABC …
BC Cancer Protocol Summary for Central Nervous …
www.bccancer.bc.ca: biopsy-proven diffuse large B-cell lymphoma with high risk of CNS involvement, but no established CNS disease a. All stages of testicular DLBCL
Protocol for the Examination of Specimens From …
www.cap.orgProtocol for the Examination of Specimens From Patients With Non-Hodgkin Lymphoma/Lymphoid Neoplasms . Version: NonHodgkin 3.2.0.1 Protocol Posting Date: October 2013 This protocol is NOT required for accreditation purposes
RCEOP in Diffuse Large B Cell Lymphoma …
www.medednhsl.comFirst line treatment of Diffuse Large B Cell Lymphoma (includes grade 3b follicular lymphoma) in patients not eligible for an anthracycline. Please note: the replacement of doxorubicin with etoposide in this patient group is established local
NCCN Clinical Practice Guidelines in Oncology …
www.nccn.orgVersion 4.2014, 08/22/14 © National Comprehensive Cancer Network, Inc. 2014, All rights reserved. The NCCN Guidelines and this illustration may not be reproduced in ...